Correlation Between Gilead Sciences and Organon

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Gilead Sciences and Organon at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Gilead Sciences and Organon into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Gilead Sciences and Organon Co, you can compare the effects of market volatilities on Gilead Sciences and Organon and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Gilead Sciences with a short position of Organon. Check out your portfolio center. Please also check ongoing floating volatility patterns of Gilead Sciences and Organon.

Diversification Opportunities for Gilead Sciences and Organon

GileadOrganonDiversified AwayGileadOrganonDiversified Away100%
0.07
  Correlation Coefficient

Significant diversification

The 3 months correlation between Gilead and Organon is 0.07. Overlapping area represents the amount of risk that can be diversified away by holding Gilead Sciences and Organon Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Organon and Gilead Sciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Gilead Sciences are associated (or correlated) with Organon. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Organon has no effect on the direction of Gilead Sciences i.e., Gilead Sciences and Organon go up and down completely randomly.

Pair Corralation between Gilead Sciences and Organon

Given the investment horizon of 90 days Gilead Sciences is expected to generate 0.6 times more return on investment than Organon. However, Gilead Sciences is 1.68 times less risky than Organon. It trades about 0.39 of its potential returns per unit of risk. Organon Co is currently generating about -0.02 per unit of risk. If you would invest  9,304  in Gilead Sciences on November 23, 2024 and sell it today you would earn a total of  1,736  from holding Gilead Sciences or generate 18.66% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Gilead Sciences  vs.  Organon Co

 Performance 
JavaScript chart by amCharts 3.21.15Dec2025Feb -50510
JavaScript chart by amCharts 3.21.15GILD OGN
       Timeline  
Gilead Sciences 

Risk-Adjusted Performance

Solid

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Gilead Sciences are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. In spite of rather unfluctuating essential indicators, Gilead Sciences exhibited solid returns over the last few months and may actually be approaching a breakup point.
JavaScript chart by amCharts 3.21.15DecJanFebJanFeb9095100105110
Organon 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Organon Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy technical and fundamental indicators, Organon is not utilizing all of its potentials. The new stock price disarray, may contribute to short-term losses for the investors.
JavaScript chart by amCharts 3.21.15DecJanFebJanFeb1414.51515.51616.517

Gilead Sciences and Organon Volatility Contrast

   Predicted Return Density   
JavaScript chart by amCharts 3.21.15-4.83-3.62-2.4-1.190.01.312.633.965.29 0.050.100.15
JavaScript chart by amCharts 3.21.15GILD OGN
       Returns  

Pair Trading with Gilead Sciences and Organon

The main advantage of trading using opposite Gilead Sciences and Organon positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Gilead Sciences position performs unexpectedly, Organon can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Organon will offset losses from the drop in Organon's long position.
The idea behind Gilead Sciences and Organon Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.

Other Complementary Tools

Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope